You've Been Exposed to Mold, But Your Genes May Be Why You're Sick.

GSTM1 is one of your cell’s primary workhorses for neutralizing and eliminating environmental toxins. It attaches glutathione, a powerful antioxidant, to harmful compounds. Once conjugated, those toxins can be excreted through bile and urine. Without GSTM1, your cells lose a major pathway for clearing pollutants, heavy metals, and carcinogens.

Here’s the problem: roughly 50% of the population carries a GSTM1 null genotype, which means the gene is completely deleted. If you have this null variant, you’re missing the entire enzyme. Your cells have zero GSTM1 activity. You still have other detoxification pathways, but you’re running on a narrower highway. Mycotoxins, benzene, pesticides, and other lipophilic toxins will clear slower and accumulate faster.

If you’re GSTM1 null, your symptoms from mold exposure tend to be more severe and longer-lasting. Brain fog doesn’t lift within weeks; it lingers for months. Respiratory irritation is more pronounced. Fatigue is deeper because your mitochondria are carrying a higher toxic load. You might notice you’re more sensitive to other chemical exposures too: perfumes, cleaning products, exhaust.

GSTP1 is another glutathione S-transferase, but it specializes in neutralizing electrophiles, the reactive molecules created by oxidative stress and environmental toxin metabolism. When your body tries to break down mycotoxins, it generates free radicals. GSTP1 catches those radicals before they damage DNA, proteins, and mitochondria.

The Ile105Val variant (Val allele) is carried by roughly 35-40% of the population. This variant reduces GSTP1 enzyme activity by 20-40%, impairing your ability to clear the oxidative byproducts of mycotoxin metabolism. You might be metabolizing the mold toxins just fine with your other detox enzymes, but the reactive intermediates and free radicals they generate aren’t being neutralized efficiently. The result is secondary damage to your cells.

You feel this as accelerated fatigue, joint pain, cognitive decline, and visible signs of oxidative stress: slow wound healing, recurrent infections, gray hair appearing earlier. Your brain and nervous system are especially vulnerable because neurons are lipid-rich and glutathione-dependent. Brain fog from mycotoxin exposure often reflects this oxidative damage.

SOD2 is the only superoxide dismutase located inside the mitochondria. It’s your first line of defense against the free radicals generated by the mitochondrial energy-production process. Mycotoxins are particularly damaging to mitochondria, so SOD2 activity is critical when you’re dealing with mold toxin exposure.

The Val16Ala variant is found in roughly 40% of people with European ancestry. The Ala allele produces less active SOD2 enzyme. When you’re exposed to mycotoxins, mitochondrial oxidative stress accumulates faster than your cells can neutralize it. Your mitochondria can’t keep pace. Energy production drops. Fatigue becomes profound and disproportionate to your activity level.

If you carry the SOD2 Ala variant and have been exposed to mold, your symptoms center on energy metabolism: you feel exhausted even after sleep, post-exertional malaise where exertion makes you worse the next day, and brain fog related to cerebral metabolic insufficiency. Muscles feel weak and heavy. Recovery from illness takes longer. This is mitochondrial oxidative stress expressing as fatigue.

MTHFR catalyzes a critical step in the methylation cycle, the metabolic pathway that produces glutathione, your most important cellular antioxidant. MTHFR also regulates the one-carbon pool, which is essential for DNA synthesis, DNA repair, and the production of SAM, the universal methyl donor your body uses for detoxification and neurotransmitter synthesis.

The C677T variant is carried by roughly 40% of people with European ancestry. This variant reduces MTHFR enzyme activity by 35-40%, slowing the methylation cycle and reducing glutathione production at the cellular level. When you’re exposed to mycotoxins, your cells need to ramp up glutathione production to neutralize the toxins. If your MTHFR is slow, you can’t produce glutathione fast enough. The toxins accumulate.

You experience this as a failure of detoxification under load. You feel fine in a clean environment, but brief mold exposure causes symptoms that persist for weeks. Your immune system stays activated because it keeps detecting the undiscarded toxins. Neurological symptoms are common: brain fog, mood changes, neuropathy. Heavy metal toxicity from mold-contaminated dust becomes worse because your heavy metal detoxification capacity depends on methylation-derived glutathione.

TNF-alpha is a pro-inflammatory cytokine. In normal amounts, it’s part of your immune response. Your immune system detects a threat and releases TNF to recruit white blood cells and activate inflammation. But TNF-alpha doesn’t distinguish between a bacterial infection and a mycotoxin. Both trigger TNF release.

The -308G>A polymorphism is carried by roughly 30% of the population. The A allele is associated with higher TNF-alpha production in response to immune triggers like mycotoxin exposure. If you carry this variant, your immune system mounts a bigger inflammatory response to mold toxins. It’s not a bigger or better response, just bigger. The inflammation itself becomes the problem.

You feel this as amplified symptoms from low-level exposure: a musty smell triggers fatigue and brain fog that lasts days. You develop chemical sensitivities and mast cell reactivity. Joint pain and muscle aches become prominent because inflammation is systemic. Sleep becomes difficult because TNF-alpha drives wakefulness and pain signaling. Over time, chronic TNF elevation contributes to immune dysregulation and autoimmune flares.

HLA-DQ2 is part of your major histocompatibility complex, the system your immune cells use to recognize foreign proteins and pathogens. It presents antigens to your T cells, training them to mount immune responses. HLA-DQ2 is particularly important for recognizing and responding to mold-derived proteins and the inflammatory byproducts of mycotoxin exposure.

HLA-DQ2 is one of the most common HLA variants in people of European and Mediterranean ancestry. If you carry HLA-DQ2, your immune system is primed to recognize certain mold antigens and mount a faster, more intense T-cell response. This can be protective against invasive fungal infection, but in the context of mold-contaminated environments and chronic low-level mycotoxin exposure, it means your immune system stays in a state of hypervigilance. You’re not just detoxifying the mycotoxins; you’re fighting the immune battle your HLA type has trained you to fight.

You experience this as persistent immune activation: elevated eosinophils, elevated inflammatory markers, difficulty downregulating after exposure, and cross-reactivity to other environmental triggers. Your body treats the mold exposure as a persistent threat. You develop sensitivity to other moldy foods (aged cheese, mushrooms, peanuts) because your immune cells have been trained to recognize mold proteins. Symptoms include respiratory reactivity, skin flushing, and neurological inflammation.